3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
11
Breast Neoplasms
10
Prostatic Neoplasms
7
Colorectal Neoplasms
7
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Hematopoietic and Lymphatic System Neoplasm
3
Hematologic Neoplasms
3
Advanced Malignant Solid Neoplasm
3
Skin Carcinoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Obesity-Related Malignant Neoplasm
2
Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Melanoma
2
Malignant Solid Neoplasm
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Carcinoma, Non-Small-Cell Lung
2
Anatomic Stage I Breast Cancer AJCC v8
2
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Syndrome
1
Substance-Related Disorders
1
Spondylitis, Ankylosing
1
Rectal Neoplasms
1
Psoriasis
1
Primary Myelofibrosis
1
Interventions
Doxorubicin
13
Specimen Handling
12
pembrolizumab
11
Magnetic Resonance Spectroscopy
10
Biopsy
10
Cyclophosphamide
9
X-Rays
7
Ifosfamide
7
Radiotherapy
6
Phantoms, Imaging
6
Gemcitabine
6
liposomal doxorubicin
5
Nivolumab
5
tazemetostat
4
palbociclib
4
fludarabine
4
atezolizumab
4
Temozolomide
4
Radiation
4
Nuclear Medicine Department, Hospital
4
Irinotecan
4
larotrectinib
3
cabozantinib
3
Surveys and Questionnaires
3
Ipilimumab
3
Carboplatin
3
Bevacizumab
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
Educational Status
×
90 days
×
Clear all
No trials found.